Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth

Suppression of RANKL-dependent heme oxygenase-1 is required for high mobility group box 1 release and osteoclastogenesis

(2011) Eiko Sakai et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function

(2011) S Vallet et al.   LEUKEMIA

Mesenchymal Stem Cells as Therapeutics

(2010) Biju Parekkadan et al.   Annual Review of Biomedical Engineering

Advances in the understanding of myeloma bone disease and tumour growth

(2010) Shmuel Yaccoby   BRITISH JOURNAL OF HAEMATOLOGY

The Pathophysiological Role of PEDF in Bone Diseases

(2010) M.L. Broadhead et al.   CURRENT MOLECULAR MEDICINE

A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients

(2010) M. Zangari et al.   HAEMATOLOGICA

Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice

(2010) Takashi Kikuiri et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Consequences of Daily Administered Parathyroid Hormone on Myeloma Growth, Bone Disease, and Molecular Profiling of Whole Myelomatous Bone

(2010) Angela Pennisi et al.   PLoS One

Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease

(2010) S. Vallet et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Human Placenta-Derived Adherent Cells Prevent Bone loss, Stimulate Bone formation, and Suppress Growth of Multiple Myeloma in Bone

(2010) Xin Li et al.   STEM CELLS

PEDF regulates osteoclasts via osteoprotegerin and RANKL

(2009) Toru Akiyama et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth

(2009) A. Pennisi et al.   BLOOD

F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

(2009) T. B. Bartel et al.   BLOOD

Sleuthing the Source of Regeneration by MSCs

(2009) Mark Pittenger   Cell Stem Cell

Intravenous hMSCs Improve Myocardial Infarction in Mice because Cells Embolized in Lung Are Activated to Secrete the Anti-inflammatory Protein TSG-6

(2009) Ryang Hwa Lee et al.   Cell Stem Cell

Mesenchymal Stem Cell Homing: The Devil Is in the Details

(2009) Jeffrey M. Karp et al.   Cell Stem Cell

Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation

(2009) Ignazio Barbagallo et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors

(2009) M Garayoa et al.   LEUKEMIA

Repair of Tissues by Adult Stem/Progenitor Cells (MSCs): Controversies, Myths, and Changing Paradigms

(2009) Darwin J Prockop   MOLECULAR THERAPY

Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging

(2009) Shannon Kidd et al.   STEM CELLS

The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo

(2008) Angela Pennisi et al.   AMERICAN JOURNAL OF HEMATOLOGY

Role of decorin in the antimyeloma effects of osteoblasts

(2008) X. Li et al.   BLOOD

Immunosuppression by mesenchymal stromal cells: From culture to clinic

(2008) Ben J. Jones et al.   EXPERIMENTAL HEMATOLOGY

Restoration of Bone Mass and Strength in Glucocorticoid-Treated Mice by Systemic Transplantation of CXCR4 and Cbfa-1 Co-Expressing Mesenchymal Stem Cells

(2008) Chun-Yang Lien et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Targeted Migration of Mesenchymal Stem Cells Modified With CXCR4 Gene to Infarcted Myocardium Improves Cardiac Performance

(2008) Zhaokang Cheng et al.   MOLECULAR THERAPY

Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone

(2008) Robert Sackstein et al.   NATURE MEDICINE

Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses

(2008) H. Ohtaki et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Autoimmune Enteropathy Independently of Regulatory T Cells

(2008) Biju Parekkadan et al.   STEM CELLS

Autologous and Allogeneic Marrow Stromal Cells Are Safe and Effective for the Treatment of Acute Kidney Injury

(2008) Florian Tögel et al.   STEM CELLS AND DEVELOPMENT

Skeletal Imaging and Management of Bone Disease

(2008) G. D. Roodman   Hematology-American Society of Hematology Education Program

Lymph node mapping in the mouse

(2007) Maria I. Harrell et al.   JOURNAL OF IMMUNOLOGICAL METHODS